Skip navigation
Momenta Pharmaceuticals names Sulat board chairman
By The Associated Press | 05 Dec 2008 | 09:52 AM ET
Text Size

CAMBRIDGE, Mass. - Biotechnology company Momenta Pharmaceuticals Inc. on Friday named James R. Sulat board chairman.

Sulat, 58, joined the board in June. He replaces Peter Barrett, who has been on the board for five years and served as chairman since June 2005.

Sulat recently served as chief financial officer and a director for Memory Pharmaceuticals Corp., which announced last month that it will be purchased by Swiss drug developer Roche for about $50 million. He also has served as president and chief executive of Memory.

Momenta shares fell 9 cents to $7.89 in morning trading.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

HOME  |  NEWS  |  MARKETS  |  EARNINGS  |  INVESTING  |  VIDEO  |  CNBC TV  |  CNBC PLUS  |  CNBC MOBILE  |  CNBC HD+
About CNBC   |   Site Map   |   Privacy Policy   |   Terms of Service   |   Advertise   |   Help   |   Feedback   |   Video Reprints
  Data is a real-time snapshot   *Data is delayed at least 15 minutes

Global Business and Financial News, Stock Quotes, and Market Data and Analysis